Southern California Alcoholic Hepatitis Consortium Administrative Core

南加州酒精性肝炎联盟行政核心

• 批准号: 9129588
• 负责人: TIMOTHY ROSS MORGAN
• 金额: $ 3万
• 依托单位: SOUTHERN CALIFORNIA INST FOR RES/EDUC
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-20 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9129588
• 关键词: Adverse event; Alcoholic Hepatitis; Alcoholic Liver Diseases; Award; Biological Assay; Blood; California; Chronic; Clinical Trials; Clinical Trials Data Monitoring Committees; Collaborations; Communication; Conflict (Psychology); Data; Disease; Electronic Mail; Enrollment; Ensure; Excision; Flow Cytometry; Functional disorder; Goals; Health; Healthcare Systems; Hepatic; Hepatocyte; Immune; Immunohistochemistry; Individual; Infection; Inflammation; Inflammatory; Injury; Injury to Liver; Investigation; Lead; Liver; Liver diseases; Minority; Mission; Mitochondria; Monitor; National Institute on Alcohol Abuse and Alcoholism; Natural regeneration; Pathway interactions; Patients; Peripheral Blood Mononuclear Cell; Persons; Plasma; Progress Reports; Proteomics; Reporting; Research; Research Personnel; Scientific Inquiry; Specialist; System; Techniques; Telephone; Testing; Work; Writing; alcohol effect; conflict resolution; cytokine; meetings; member; novel therapeutics; prednisolone; problem drinker; transcriptomics

DESCRIPTION (provided by applicant): Alcoholic hepatitis is an inflammatory disease of the liver that occurs for unknown reasons in a minority of chronic alcoholic patients. The pathophysiology of alcoholic hepatitis is incompletely understood and prednisolone, the recommended treatment for severe alcoholic hepatitis, is ineffective in a significant proportion of patients. Improvements in alcoholic hepatitis will require testing of new drugs and detailed investigations of liver and blood using broad, hypothesis independent approaches (e.g., proteomics and transcriptomics) as well as focused, hypothesis driven investigations. The overall aims of the administrative core are to provide administrative support for the scientific missions and specific aims of the individual U01 projects, to assist the External Advisory Board with oversight of the consortium, and to ensure the objectives of the NIAAA are achieved. In particular, this consortium is focused on understanding and treating hepatic inflammation and exploring pathways of hepatocyte injury and regeneration in alcoholic hepatitis. The main project in the consortium is a clinical trial of new treatments for alcoholic hepatitis. The five oher translational projects will explore immune status, transcriptomics of the liver, proteomics of the liver, hepatocyte mitochondrial damage, pathways of hepatocyte injury, and inhibition of hepatocyte regeneration. Collaboration among projects is central to understanding the pathophysiology of alcoholic hepatitis. The administrative core will be responsible for oversight of the projects, encouraging collaboration, monitoring progress of individual projects, resolving conflicts, evaluating the addition of new investigators, responding to scientific inquiries relatedto the research, and maintaining communication with the NIAAA. This U01 consortium and the administrative core support the NIAAA's mission of understanding the health effects of alcohol, including the pathophysiology and treatment of alcoholic liver injury.

描述（由申请人提供）：酒精性肝炎是一种肝脏炎症性疾病，发生在少数慢性酒精中毒患者中，原因不明。酒精性肝炎的病理生理学尚不完全清楚，推荐用于治疗重度酒精性肝炎的泼尼松龙在很大一部分患者中无效。 患者酒精性肝炎的改善将需要使用广泛的、假设独立的方法（例如，蛋白质组学和转录组学）以及有重点的假设驱动的研究。行政核心的总体目标是为科学任务和各个U01项目的具体目标提供行政支持，协助外部咨询委员会监督联合体，并确保实现NIAAA的目标。特别是，该联盟专注于了解和治疗肝脏炎症，并探索酒精性肝炎中肝细胞损伤和再生的途径。该联盟的主要项目是酒精性肝炎新疗法的临床试验。其他五个翻译项目将探索免疫状态，肝脏转录组学，肝脏蛋白质组学，肝细胞线粒体损伤，肝细胞损伤途径和肝细胞再生抑制。项目之间的合作是了解酒精性肝炎病理生理学的核心。行政核心将负责监督项目，鼓励合作，监测单个项目的进展，解决冲突，评估新研究人员的增加，回应与研究有关的科学询问，并保持与NIAAA的沟通。这个U01联盟和管理核心支持NIAAA了解酒精对健康影响的使命，包括酒精性肝损伤的病理生理学和治疗。

项目成果

Nasal bridles for securing nasoenteric tubes: a meta-analysis.

• DOI: 10.1177/0884533614536737
• 发表时间: 2014-10
• 期刊: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
• 作者: Bechtold ML;Nguyen DL;Palmer LB;Kiraly LN;Martindale RG;McClave SA
• 通讯作者: McClave SA

Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

肝性脑病的蛋白质限制适合特定的患者：一种观点。

• DOI: 10.1007/s12072-013-9497-1
• 发表时间: 2014
• 期刊: Hepatology international
• 影响因子: 6.6
• 作者: Nguyen,DouglasL;Morgan,Timothy
• 通讯作者: Morgan,Timothy